https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-25 / Cancer Immunol. Immunother. 2009 Jun;58(6):901-13
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-25 / Cancer Immunol. Immunother. 2009 Jun;58(6):901-132008-10-25 00:00:002019-02-15 08:44:25Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-23 / Exp. Dermatol. 2009 Apr;18(4):396-403
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-23 / Exp. Dermatol. 2009 Apr;18(4):396-4032008-10-23 00:00:002019-02-15 09:19:13The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-18 / Neurol. Res. 2009 Feb;31(1):3-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-18 / Neurol. Res. 2009 Feb;31(1):3-102008-10-18 00:00:002019-02-15 09:00:15Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-08 / Clin. Immunol. 2008 Dec;129(3):482-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-08 / Clin. Immunol. 2008 Dec;129(3):482-912008-10-08 00:00:002019-02-15 09:19:18Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-02 / Cell. Immunol. 2009;254(2):135-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-02 / Cell. Immunol. 2009;254(2):135-412008-10-02 00:00:002019-02-15 09:02:59The anti-tumor effect of human monocyte-derived dendritic cells loaded with HSV-TK/GCV induced dying cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-01 / Int. J. Oncol. 2008 Oct;33(4):823-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-01 / Int. J. Oncol. 2008 Oct;33(4):823-322008-10-01 00:00:002021-11-15 17:03:44Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-01 / J. Immunother. 2008 Oct;31(8):771-80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-01 / J. Immunother. 2008 Oct;31(8):771-802008-10-01 00:00:002019-02-15 09:16:52Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial
